Travere Therapeutics, Inc. TVTX Change in Other Liabilities
Change in Other Liabilities at other companies
Other financials
Where this comes from
Reported directly by Travere Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingLiabilities.
The official record: Travere Therapeutics, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Travere Therapeutics, Inc.'s change in other liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Travere Therapeutics, Inc.'s change in other liabilities?
- Travere Therapeutics, Inc. (TVTX) reported change in other liabilities of $1.94M in Q1 2026.
- How has Travere Therapeutics, Inc.'s change in other liabilities changed year-over-year?
- Travere Therapeutics, Inc.'s change in other liabilities increased by 173.6% year-over-year, from $709K to $1.94M.
- What does change in other liabilities mean?
- Change in miscellaneous liabilities affecting operating cash flow.